The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Melatonin: From Basic Research to Cancer Treatment Clinics
Abstract
ABSTRACT: Melatonin, the chief secretory product of the pineal gland, is a direct free radical scavenger, an indirect antioxidant, as well as an important immunomodulatory agent. In both in vitro and in vivo investigations, melatonin protected healthy cells from radiation-induced and chemotherapeutic drug–induced toxicity. Furthermore, several clinical studies have demonstrated the potential of melatonin, either alone or in combination with traditional therapy, to yield a favorable efficacy to toxicity ratio in the treatment of human cancers. This study reviews the literature from laboratory investigations that document the antioxidant and oncostatic actions of melatonin and summarizes the evidence regarding the potential use of melatonin in cancer treatment. This study also provides rationale for the design of larger translational research–based clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide
Pryor, W. A., & Squadrito, G. L. (1995) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1995.268.5.l699 · Cited by 1,511
Reppert, S. M., Weaver, D. R., & Ebisawa, T. (1994) · Neuron · doi:10.1016/0896-6273(94)90055-8 · Cited by 1,096
Melatonin Prevents Death of Neuroblastoma Cells Exposed to the Alzheimer Amyloid Peptide
Pappolla, M. A., Sos, M., Omar, R. A., Bick, R. J., Hickson-Bick, D. L. M., Reiter, R. J., Efthimiopoulos, S., & Robakis, N. K. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01683.1997 · Cited by 359
Gitto, E., Tan, D.-X., Reiter, R. J., Karbownik, M., Manchester, L. C., Cuzzocrea, S., Fulia, F., & Barberi, I. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011777747 · Cited by 196
Self-citationDreher, Gabard, Schwindt, & Maibach (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02447.x · Cited by 163
Daily rhythm of serum melatonin in patients with dementia of the degenerate type
Uchida, K., Okamoto, N., Ohara, K., & Morita, Y. (1996) · Brain Research · doi:10.1016/0006-8993(96)00086-8 · Cited by 138
Day-time melatonin administration: Effects on core temperature and sleep onset latency
REID, K., VAN DEN HEUVEL, C., & DAWSON, D. (1996) · Journal of Sleep Research · doi:10.1046/j.1365-2869.1996.t01-1-00006.x · Cited by 99
Use of melatonin for sleep and circadian rhythm disorders
Sack, R. L., Lewy, A. J., & Hughes, R. J. (1998) · Annals of Medicine · doi:10.3109/07853899808999393 · Cited by 80
Cited by
Melatonin: Nature’s most versatile biological signal?
Pandi‐Perumal, S. R., Srinivasan, V., Maestroni, G. J. M., Cardinali, D. P., Poeggeler, B., & Hardeland, R. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05322.x · Cited by 875
Night work and risk of breast cancer
Schernhammer, E. S., Kroenke, C. H., Laden, F., & Hankinson, S. E. (2006) · Epidemiology · doi:10.1097/01.ede.0000190539.03500.c1 · Cited by 484
Night work and breast cancer risk: A systematic review and meta-analysis
Megdal, S. P., Kroenke, C. H., Laden, F., Pukkala, E., & Schernhammer, E. S. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.05.010 · Cited by 482
Hypotheses for mechanisms linking shiftwork and cancer
Fritschi, L., Glass, D. C., Heyworth, J. S., Aronson, K., Girschik, J., Boyle, T., Grundy, A., & Erren, T. C. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.06.002 · Cited by 201
Melatonin as a biomarker of circadian dysregulation
Mirick, D. K., & Davis, S. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0605 · Cited by 176
Metadata
- Authors
- Vijayalaxmi, Thomas, C. R., Reiter, R. J., & Herman, T. S.
- Venue
- Journal of Clinical Oncology
- Published
- 2002-05-15
- Volume
- 20
- Issue
- 10
- Pages
- 2575-2601
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2105864875
- Cited by
- 361
- References
- 8
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Melatonin: From Basic Research to Cancer Treatment Clinics. https://app.cochat.ai/papers/10.1200/jco.2002.11.004
- The paper
- Vijayalaxmi, Thomas, C. R., Reiter, R. J., & Herman, T. S. (2002). Melatonin: From Basic Research to Cancer Treatment Clinics. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2002.11.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.